Pharma giant Merck created a completely bogus medical journal creatively entitled the Australian Journal of Bone and Joint Medicine to publish data favorable to its products. This really comes as no surprise at the hands of a pharma company whose faulty data (which probably had its genesis in other phony peer-reviewed throwaways) led to the yanking of Vioxx from the pharma marketplace almost five years ago and its current struggles with personal injury payouts to this day. As much as it is tremendously easy to point the finger at the pharma company in instances like these, some of the fault has to lie with physicians and healthcare organizations who, without sound policies policing the matter, lend their (financial) resources to these shady projects. | LINK

Related Posts Within Doctor Pundit:

1. Pharma Company Prepares to Revolutionize anti-TB Treatment with 2 Currently Used Antibiotics Recently this blog introduced its readers to a new drug...
2. Pharma Company Debuts New Schizophrenia Drug Amid High Stakes Reform Debate If you’re a pharma company that thrives on innovation (and,...
3. Pharma Company Goes on the Defensive Amid New Avandia Attacks A safety review of GSK’s Avandia, under fire and intense...
4. Report: Pharma Company Covered Up Known Cardiovascular Risks of Drug GSK (then known as SmithKline Beecham) knew in a 1999...
5. Pharma Company Forges Partnership to Create Genetic Therapies for Rare Diseases In an otherwise dull year for novel drug development, GSK...